{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:13:28Z","timestamp":1792098808906,"version":"4.4.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1681\/asn.2012111094","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T01:39:07Z","timestamp":1396575547000},"page":"2231-2240","source":"Crossref","is-referenced-by-count":67,"title":["Myeloid Mineralocorticoid Receptor Activation Contributes to Progressive Kidney Disease"],"prefix":"10.1681","volume":"25","author":[{"given":"Louis L.","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Nikolic-Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyce","family":"Ozols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Y.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morag J.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg H.","family":"Tesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20230208","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ajh.2011.245","article-title":"Mineralocorticoid receptor-associated hypertension and its organ damage: Clinical relevance for resistant hypertension.","volume":"25","author":"Shibata","year":"2012","journal-title":"Am J Hypertens"},{"key":"R2-14-20230208","first-page":"606","article-title":"The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomeru-lonephritis.","volume":"4","author":"Zitt","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"key":"R3-14-20230208","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5301\/jn.5000125","article-title":"Aldosterone mediates glomerular inflammation in experimental mesangial proliferative glomerulonephritis.","volume":"26","author":"Qin","year":"2012","journal-title":"J Nephrol"},{"key":"R4-14-20230208","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/ndt\/gfr495","article-title":"Long-term mineralocorticoid receptor blockade ameliorates progression of experimental diabetic renal disease.","volume":"27","author":"Lian","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R5-14-20230208","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1681\/ASN.2005111196","article-title":"Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.","volume":"17","author":"Han","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R6-14-20230208","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1210\/en.2006-0944","article-title":"Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.","volume":"147","author":"Guo","year":"2006","journal-title":"Endocrinology"},{"key":"R7-14-20230208","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.2337\/diacare.28.9.2106","article-title":"Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: A randomized, double-masked, cross-over study.","volume":"28","author":"Rossing","year":"2005","journal-title":"Diabetes Care"},{"key":"R8-14-20230208","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/01.hjh.0000249708.44016.5c","article-title":"Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.","volume":"24","author":"van den Meiracker","year":"2006","journal-title":"J Hypertens"},{"key":"R9-14-20230208","doi-asserted-by":"crossref","first-page":"e26904","DOI":"10.1371\/journal.pone.0026904","article-title":"Moderate antiproteinuric effect of add-on aldosterone blockade with eplerenone in non-diabetic chronic kidney disease. A randomized cross-over study.","volume":"6","author":"Boesby","year":"2011","journal-title":"PLoS ONE"},{"key":"R10-14-20230208","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.HYP.0000193502.77417.17","article-title":"Mechanisms of mineralocorticoid action.","volume":"46","author":"Fuller","year":"2005","journal-title":"Hypertension"},{"key":"R11-14-20230208","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1124\/jpet.109.158113","article-title":"Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats.","volume":"332","author":"Nishiyama","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"R12-14-20230208","doi-asserted-by":"crossref","first-page":"F1381","DOI":"10.1152\/ajprenal.00101.2009","article-title":"Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions.","volume":"297","author":"Lee","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R13-14-20230208","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/01.CIR.0000127949.05756.9D","article-title":"Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: A possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.","volume":"109","author":"Keidar","year":"2004","journal-title":"Circulation"},{"key":"R14-14-20230208","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.109.131110","article-title":"Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone\/salt-induced cardiac fibrosis and increased blood pressure.","volume":"54","author":"Rickard","year":"2009","journal-title":"Hypertension"},{"key":"R15-14-20230208","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1172\/JCI41080","article-title":"Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice.","volume":"120","author":"Usher","year":"2010","journal-title":"J Clin Invest"},{"key":"R16-14-20230208","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/STROKEAHA.110.598441","article-title":"Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia.","volume":"42","author":"Frieler","year":"2011","journal-title":"Stroke"},{"key":"R17-14-20230208","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1523-1755.2000.00364.x","article-title":"CD44-mediated neutrophil apoptosis in the rat.","volume":"58","author":"Takazoe","year":"2000","journal-title":"Kidney Int"},{"key":"R18-14-20230208","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.HYP.0000157408.43807.5a","article-title":"Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCepsilon-MAPK-p90RSK, and Rho-kinase pathway.","volume":"45","author":"Kobayashi","year":"2005","journal-title":"Hypertension"},{"key":"R19-14-20230208","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1210\/en.2011-2098","article-title":"Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis.","volume":"153","author":"Bienvenu","year":"2012","journal-title":"Endocrinology"},{"key":"R20-14-20230208","doi-asserted-by":"crossref","first-page":"F1043","DOI":"10.1152\/ajprenal.00389.2012","article-title":"Role of macrophages in the fibrotic phase of rat crescentic glomerulonephritis.","volume":"304","author":"Han","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"R21-14-20230208","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10557-006-8130-0","article-title":"The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.","volume":"20","author":"Tsukamoto","year":"2006","journal-title":"Cardiovasc Drugs Ther"},{"key":"R22-14-20230208","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1479-5876-9-180","article-title":"The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism.","volume":"9","author":"Eudy","year":"2011","journal-title":"J Transl Med"},{"key":"R23-14-20230208","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1159\/000228080","article-title":"Aldosterone induces apoptosis in rat podocytes: Role of PI3-K\/Akt and p38MAPK signaling pathways.","volume":"113","author":"Chen","year":"2009","journal-title":"Nephron, Exp Nephrol"},{"key":"R24-14-20230208","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.HYP.0000255636.11931.a2","article-title":"Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.","volume":"49","author":"Shibata","year":"2007","journal-title":"Hypertension"},{"key":"R25-14-20230208","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/gene.10164","article-title":"Podocyte-specific expression of cre recombinase in transgenic mice.","volume":"35","author":"Moeller","year":"2003","journal-title":"Genesis"},{"key":"R26-14-20230208","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1046\/j.1523-1755.2001.00940.x","article-title":"LF15-0195 prevents the induction and inhibits the progression of rat anti-GBM disease.","volume":"60","author":"Tesch","year":"2001","journal-title":"Kidney Int"},{"key":"R27-14-20230208","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0002-9440(10)64239-3","article-title":"A new method for large scale isolation of kidney glomeruli from mice.","volume":"161","author":"Takemoto","year":"2002","journal-title":"Am J Pathol"},{"key":"R28-14-20230208","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1007\/s00125-010-1757-1","article-title":"Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury.","volume":"53","author":"Lim","year":"2010","journal-title":"Diabetologia"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201410000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:24:09Z","timestamp":1786130649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201410000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2012111094","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}